September 2, 1999
MEDIA CONTACT: Barb Chamberlain, 509/358-7527, email@example.com
STORY SOURCE: David Sclar, 509/335-8039, firstname.lastname@example.org
WSU SPOKANE NAMES BOEING DISTINGUISHED
PROFESSOR IN HEALTH POLICY
SPOKANE, Wash. -- Washington State University's David A. Sclar has been named the Boeing Distinguished Professor in Health Policy, a position established at WSU Spokane.
WSU President Samuel H. Smith made the announcement during the groundbreaking ceremonies Thursday for WSU Spokane's new Health Sciences Building, which is to be constructed at the 44-acre Riverpoint Higher Education Park.
Sclar, a professor of health policy and administration, is also the Boehringer Ingelheim Scholar in Pharmaceutical Economics, and director of the pharmacoeconomics and pharmacoepidemiology research unit at the WSU College of Pharmacy.
His research focuses on pharmaceutical economics and health policy. Recent published findings from his research include a study concluding that race and socioeconomic status influence the prescription of antidepressants (Harvard Review of Psychiatry, May/June 1999), and a study indicating that attention-deficit/hyperactivity disorder and Ritalin prescriptions are rising rapidly (Clinical Pediatrics, April 1999).
In 1998 Sclar received the Teacher of the Year Award from the WSU pharmacy college. Sclar also has awards from the American Society of Health-System Pharmacists Research and Education Foundation for his research in pharmacotherapy and in pharmacy practice.
Prior to coming to WSU, Sclar received the Teacher of the Year Award two years in a row from the University of Southern California pharmacy school.
Winsor Schmidt, director of the health policy and administration program at WSU Spokane, says, "We are honored to have the first distinguished professorship to be established at WSU Spokane. Dr. Sclar's scholarship will contribute to the strengthening of our research partnerships in Spokane, the education available to our students in the classroom, and the contribution our program makes to improved health and quality of life for the people of Washington."
The Distinguished Professorship in Health Policy will be based in the College of Pharmacy that has programs in Pullman and Spokane. WSU Spokane is home to a number of graduate programs in the health sciences, including the doctor of pharmacy program and the master of health policy and administration.
Funded initially in 1993 with a gift of $250,000 from The Boeing Company, the professorship received matching funds from the state during the 1998 legislative session. Endowed professorships enable public universities to recruit and retain outstanding teachers and scholars by providing increased funding for teaching and research in faculty positions.
William Fassett, dean of WSU's pharmacy college, says, "Dr. Sclar is nationally and internationally recognized for work in the economics of drug use in health care. He has addressed such important topics as breast cancer screening, use of antihypertensives and approaches to appropriate treatments for diseases such as diabetes and mental illness. His research has important implications for health policy in the state of Washington and beyond. We are pleased that the resources made available by the Boeing endowment will help support Dr. Sclar's continuing research."
Sclar's research has been funded by a wide variety of sources, including industry, foundations, and United States and Canadian government entities.
Note to reporters and editors: A biographical overview of Dr. Sclar's career is available.
News releases on the studies described above are online at:
<http://www.wsu.edu/ NIS/releases2/hi1401htm> (ADHD/Ritalin)
Office of News & Information Services
Washington State University | Pullman, WA 99164-1040
Phone: 509/335-3581 | FAX: 509/335-0932 | E-mail: email@example.com